Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Surveillance of Opioid Prescribing as a Public Health Intervention: Washington State Bree Collaborative Opioid Metrics.

Fulton-Kehoe D, Von Korff M, Mai J, Weir V, Lofy KH, Sabel J, Tauben D, Franklin G.

J Public Health Manag Pract. 2019 Aug 21. doi: 10.1097/PHH.0000000000001067. [Epub ahead of print]

PMID:
31441793
2.

Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.

Paulozzi LJ, Strickler GK, Kreiner PW, Koris CM; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.

PMID:
26469747
3.

Trends in Opioid Dosing Among Washington State Medicaid Patients Before and After Opioid Dosing Guideline Implementation.

Sullivan MD, Bauer AM, Fulton-Kehoe D, Garg RK, Turner JA, Wickizer T, Franklin GM.

J Pain. 2016 May;17(5):561-8. doi: 10.1016/j.jpain.2015.12.018. Epub 2016 Jan 30.

PMID:
26828802
4.

Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.

Jayawardhana J, Abraham AJ, Perri M.

J Manag Care Spec Pharm. 2018 Sep;24(9):886-894. doi: 10.18553/jmcp.2018.24.9.886.

5.

Prescription of Controlled Substances: Benefits and Risks.

Preuss CV, Kalava A, King KC.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 May 10.

6.

The effects of state rules on opioid prescribing in Indiana.

Al Achkar M, Grannis S, Revere D, MacKie P, Howard M, Gupta S.

BMC Health Serv Res. 2018 Jan 18;18(1):29. doi: 10.1186/s12913-018-2830-6.

7.

Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach.

Losby JL, Hyatt JD, Kanter MH, Baldwin G, Matsuoka D.

J Eval Clin Pract. 2017 Dec;23(6):1173-1179. doi: 10.1111/jep.12756. Epub 2017 Jul 14.

PMID:
28707421
8.

Opioid poisonings in Washington State Medicaid: trends, dosing, and guidelines.

Fulton-Kehoe D, Sullivan MD, Turner JA, Garg RK, Bauer AM, Wickizer TM, Franklin GM.

Med Care. 2015 Aug;53(8):679-85. doi: 10.1097/MLR.0000000000000384.

PMID:
26172937
9.

Opioid prescribing patterns after dental visits among beneficiaries of Medicaid in Washington state in 2014 and 2015.

Obadan-Udoh E, Lupulescu-Mann N, Charlesworth CJ, Muench U, Jura M, Kim H, Schwarz E, Mertz E, Sun BC.

J Am Dent Assoc. 2019 Apr;150(4):259-268.e1. doi: 10.1016/j.adaj.2018.12.030.

PMID:
30922457
10.

The Impact of Opioid Risk Reduction Initiatives on High-Dose Opioid Prescribing for Patients on Chronic Opioid Therapy.

Von Korff M, Dublin S, Walker RL, Parchman M, Shortreed SM, Hansen RN, Saunders K.

J Pain. 2016 Jan;17(1):101-10. doi: 10.1016/j.jpain.2015.10.002. Epub 2015 Oct 22.

11.

Tracking Opioid Prescribing Metrics in Washington State (2012-2017): Differences by County-Level Urban-Rural and Economic Distress Classifications.

Sears JM, Edmonds AT, Fulton-Kehoe D.

J Rural Health. 2019 Oct 4. doi: 10.1111/jrh.12400. [Epub ahead of print]

PMID:
31583779
12.

Changes in opioid prescribing for chronic pain in Washington State.

Franklin GM, Fulton-Kehoe D, Turner JA, Sullivan MD, Wickizer TM.

J Am Board Fam Med. 2013 Jul-Aug;26(4):394-400. doi: 10.3122/jabfm.2013.04.120274.

13.

Opioid Prescribing Laws and Emergency Department Guidelines for Chronic Non-Cancer Pain in Washington State.

Skaer TL, Nwude AC.

Pain Pract. 2016 Jun;16(5):642-7. doi: 10.1111/papr.12359. Epub 2015 Sep 15. Review.

PMID:
26369588
14.

Trends in average days' supply of opioid medications in Medicaid and commercial insurance.

Tehrani AB, Henke RM, Ali MM, Mutter R, Mark TL.

Addict Behav. 2018 Jan;76:218-222. doi: 10.1016/j.addbeh.2017.08.005. Epub 2017 Aug 19.

PMID:
28858693
15.

Opioid prescribing for chronic musculoskeletal pain in UK primary care: results from a cohort analysis of the COPERS trial.

Ashaye T, Hounsome N, Carnes D, Taylor SJC, Homer K, Eldridge S, Spencer A, Rahman A, Foell J, Underwood MR; COPERS Study Team (ISRCTN 24426731).

BMJ Open. 2018 Jun 6;8(6):e019491. doi: 10.1136/bmjopen-2017-019491.

16.

Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics.

Willy ME, Graham DJ, Racoosin JA, Gill R, Kropp GF, Young J, Yang J, Choi J, MaCurdy TE, Worrall C, Kelman JA.

Pain Med. 2014 Sep;15(9):1558-68. doi: 10.1111/pme.12459. Epub 2014 May 15.

PMID:
24828968
17.

Bending the prescription opioid dosing and mortality curves: impact of the Washington State opioid dosing guideline.

Franklin GM, Mai J, Turner J, Sullivan M, Wickizer T, Fulton-Kehoe D.

Am J Ind Med. 2012 Apr;55(4):325-31. doi: 10.1002/ajim.21998. Epub 2011 Dec 27.

PMID:
22213274
18.

An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.

Guy GP Jr, Zhang K, Halpin J, Sargent W.

Am J Prev Med. 2019 Sep 27. pii: S0749-3797(19)30274-0. doi: 10.1016/j.amepre.2019.06.007. [Epub ahead of print]

PMID:
31564606
19.

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study.

Sharma V, Weir D, Samanani S, Simpson SH, Gilani F, Jess E, Eurich DT.

BMJ Open. 2019 Sep 6;9(9):e030858. doi: 10.1136/bmjopen-2019-030858.

20.

The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program.

Kim H, Hartung DM, Jacob RL, McCarty D, McConnell KJ.

Psychiatr Serv. 2016 Apr 1;67(4):397-404. doi: 10.1176/appi.ps.201500116. Epub 2016 Jan 14.

Supplemental Content

Support Center